Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
about
Fluoxetine prevents 8-OH-DPAT-induced hyperphagia in Fischer inbred ratsEpidemiology, diagnosis, and management of depression in patients with CKD.Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients.Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.Sequence variants of the HTR3A gene contribute to the genetic prediction of postoperative nausea in Taiwan.
P2860
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
@en
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
@nl
type
label
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
@en
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
@nl
prefLabel
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
@en
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
@nl
P2093
P356
P1433
P1476
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
@en
P2093
Jun Nakamura
Koji Shinkai
Nobuhisa Ueda
Reiji Yoshimura
Yumi Sakata
P356
10.1159/000071826
P577
2003-01-01T00:00:00Z